NOTICE: Many events listed here have been canceled or postponed due to the Covid-19 emergency. It is best to call ahead or check with organizer's websites to verify the status of any local event.

Change Location × Boston

    Recent Locations

      Protein Misfolding Drug Discovery Summit in Boston

      • Protein Misfolding Drug Discovery Summit Photo #1
      1 of 1
      October 27, 2020

      Tuesday   9:00 AM - 5:00 PM (daily until October 29, 2020)

      10 Huntington Ave
      Boston, Massachusetts 02116

      • No Performers Listed
      Protein Misfolding Drug Discovery Summit

      Successfully Validate Novel Targets, Improve Preclinical Predictability of Patient-Derived Models and Optimize Drug Pharmacology to Accelerate Translation of Robust Protein Misfolding Targeted Therapeutics into the Clinic. With numerous molecular approaches emerging that demonstrate viable efficacy of targeting protein misfolding and aggregation, join the Protein Misfolding Drug Discovery Summit - the only industry and translational focused conference dedicated to the discovery and translation of disruptive disease-modifying therapeutics with optimized pharmacology to target protein misfolding in proteopathies and cancer.

      Speakers: Matthew Townsend Global Director of Proteostasis, Alzheimer's Disease AbbVie, Christopher Missling President and CEO Anavex Life Sciences, Michele Vendruscolo Professor and CSO Cambridge University Centre for Misfolding Diseases and Wren Therapeutics, Gergely Toth Founder and CEO CantaBio Pharmaceuticals, Suchira Bose Research Advisor and Head of Molecular Pathology, Neuroscience Eli Lilly, David Lynn HHMI Professor Emory University, Zhexing Wen Assistant Professor Emory University, Peter Lansbury CSO Lysosomal Therapeutics, Aubin Michalon Principal Scientist Neurimmune, Rick Morimoto Professor Northwestern University, Neil Cashman CSO and Co-Founder ProMIS Neurosciences, Wagner Zago CSO Prothena, Judith Frydman Professor Stanford University, Marcia Taylor VP Research and Neurodegeneration Alliance Manager Treventis, David Smith Associate Professor West Virginia University, Johnny Habchi Head of Research Wren Therapeutics, Kenneth Rhodes CSO Yumanity

      Cost: Payment required - conference + 2 workshops (Industry): USD 4097.00, conference + 1 workshop (Industry): USD 3498.00, conference only (Industry): USD 2899.00, workshop only (Industry): USD 699.00

      Categories: Conferences & Tradeshows | Health & Wellness

      This event repeats daily until October 29, 2020:

      Website | Tickets
      Event details may change at any time, always check with the event organizer when planning to attend this event or purchase tickets.

      Hotels and Airbnbs near Protein Misfolding Drug Discovery Summit. Book your stay now!